Skip to main content

Advertisement

Table 1 Demographic table for training and validation HCV-related cirrhosis cohorts

From: Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran’s Affairs Health Care System

  Training cohort Validation cohort
  Controls HCC cases Controls HCC cases
N 5611 451 5611 451
Age at baseline (years) 52.87 (7.28) 54.67 (7.78) 52.93 (7.39) 54.89 (7.49)
Male 5498 (97.99%) 449 (99.56%) 5501 (98.04%) 447 (99.11%)
Female 113 (2.01%) 2 (0.44%) 110 (1.96%) 4 (0.89%)
Race     
White 1954 (34.82%) 173 (38.36%) 2034 (36.25%) 171 (37.92%)
Black 623 (11.10%) 54 (11.97%) 576 (10.27%) 60 (13.30%)
Other/Unknown 3034 (54.07%) 224 (49.67%) 3001 (53.48%) 220 (48.78%)
Number of AFP tests     
1 1598 (28.48%) 116 (25.72%) 1598 (28.48%) 138 (30.60%)
2 1297 (23.12%) 119 (26.39%) 1240 (22.10%) 106 (23.50%)
3-4 1480 (26.38%) 119 (26.39%) 1524 (27.16%) 120 (26.61%)
> 4 1236 (22.03%) 97 (21.51%) 1249 (22.26%) 87 (19.29%)
Months between AFP tests 11.67 (11.00) 10.30 (10.10) 11.83 (11.26) 10.93 (10.89)
Baseline AFP in log2(ng/ml) 2.92 (1.55) 4.72 (2.78) 2.95 (1.57) 4.57 (2.95)
Baseline ALT in log2(ng/ml) 6.14 (1.03) 6.31 (0.91) 6.16 (1.05) 6.35 (0.88)
Baseline PLT in 1000’s 147.97 (78.88) 123.50 (66.06) 148.51 (78.83) 127.97 (76.08)
  1. For continuous variables we report means and standard deviations in parenthesis and for categorical variables we report the number in each group and percentages in parenthesis. Baseline was defined to be the date of the first AFP test